Oncology News | pharmaphorum

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

AZ's Imfinzi/Imjudo combo backed in EU for liver, lung cance...

AstraZeneca's oncology portfolio continues to deliver, with a recommendation for EU approval of its new Imfinzi/Imjudo immunotherapy combination heading a flurry of regulatory updates.

News

FDA approves Adstiladrin as first gene therapy for NMIBC

The US Food and Drug Administration (FDA) has

News

Second phase 3 trial extends Astellas' lead in claudin 18.2 ...

Astellas has confirmed it is out in front among developers of drugs targeting claudin 18.2, after a second phase 3 trial of zolbetuximab hit its objectives.

News

FDA says yes to MedCognetics breast cancer screening AI

Digital health company MedCognetics has picked up an FDA approval for QmTRIAGE, its artificial intelligence-powered software for detecting breast cancer in medical images.

News

ASH roundup: late breakers take the stage

The final day of the ASH congress always includes a session on late-breaking studies, and this year was no exception, with presentations on Novartis' iptacopan in paroxysmal nocturnal haemo

News

Merck and Moderna's mRNA cancer vaccine aces its first effic...

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna.

AZ's Imfinzi/Imjudo combo backed in EU for liver, lung cance...

FDA approves Adstiladrin as first gene therapy for NMIBC

Second phase 3 trial extends Astellas' lead in claudin 18.2 ...

FDA says yes to MedCognetics breast cancer screening AI

ASH roundup: late breakers take the stage

Merck and Moderna's mRNA cancer vaccine aces its first effic...

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks